RxDoctor Payments Data

Christopher Naismith

Nurse Practitioner · Ann Arbor, MINPI 1275984809

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,658 of the $10,400 with a category attached, or 83.3%. It is spread thinly across 52 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,400in general payments, 2019–2025

Across 427 payments — averaging $24.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$2K
  • AstraZeneca$2K
  • Jazz Pharmaceuticals Inc.$775
  • GSK$656
  • Boehringer Ingelheim$457
  • Regeneron Healthcare Solutions, Inc.$430
  • plus $4K from 46 others

What the payments were for

  • Travel & lodging$1,27912%
  • Food & beverage$8,65883%
  • Education$4634%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,400 in reported general payments places this provider in the 95th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
OfevNintedanib Esylate31$382,358
Trelegy ElliptaFluticasone/Umeclidin/Vilanter340$350,105
XywavSodium,calcium,mag,pot Oxybate11$213,894
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr153$111,520
Fasenra PenBenralizumab15$85,334
Breztri AerosphereBudesonide/Glycopyr/Formoterol93$82,211
Ambrisentan12$74,164
Dupixent PenDupilumab18$65,741
Stiolto RespimatTiotropium Br/Olodaterol Hcl75$56,305
Spiriva RespimatTiotropium Bromide45$51,434
Dupixent SyringeDupilumab12$45,754
Breo ElliptaFluticasone/Vilanterol52$44,460
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate78$37,855
Tiotropium Bromide28$28,592
Incruse ElliptaUmeclidinium Bromide35$17,121

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta$656$523,207580 claims
Boehringer IngelheimOfev, Stiolto Respimat, Spiriva Respimat$457$490,097151 claims
AstraZenecaBreztri Aerosphere, Symbicort$1,528$87,799111 claims
Teva Pharmaceuticals USA, Inc.Qvar Redihaler$36$3,63212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,351 nurse practitioner providers in Michigan.

Other nurse practitioner in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →